Elsevier Resumes Review of Debated Hydroxychloroquine COVID-19 Research
Elsevier has reignited an examination of a controversial study on hydroxychloroquine's impact on COVID-19 patients, originally published in *The Lancet*. The research, which significantly influenced global health policies, faced intense criticism over methodology and data reliability provided by Surgisphere. This renewed investigation aims to clarify the study's integrity and its influence on public health decisions.
- July 30 2024
- Jasper Thorneville
- Permalink
- Elsevier Hydroxychloroquine COVID-19 Surgical Research
- 0 Comments